← brief for 2026-09-22 · Slowing decline

Erythropoiesis-stimulating agent hyporesponsiveness in chronic kidney disease: mechanistic insights and emerging precision approaches

Article No results yet Peer reviewed

Key takeaways

This review explains why some people with kidney disease do not respond well to anemia drugs. It describes the body's internal reasons, but it does not report new trial results.

Who did this work

Haifeng Zhang (Second Hospital of Shandong University) · Zihao Zhu (Second Hospital of Shandong University) · Xuexun Chen (Second Hospital of Shandong University) · Xuan Li (Second Hospital of Shandong University) · Jigang Shan

Source

Article · OpenAlex, CKD works · 2026-09-22
https://doi.org/10.3389/fmed.2026.1862346